Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Curriculum updated on 06/01/2021
-
Transgender Health Program Integrated Into HIV Prevention and Care
The Rutgers New Jersey Medical School created a transgender health program and integrated it into their Infectious Disease Practice. The program conducted community outreach to engage transgender men and women in care, trained all staff on gender affirming care, hired transgender staff, provided gender affirming care and hormone treatments onsite, and offered mental health support to patients.Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
-
Kansas City, MO: KC Life 360
KC Life 360’s same-day intake, informed consent, and one-on-one with an Employment Career Specialist generates awareness of services and benefits across provider networks.Resource updated 09/14/2023
-
PACT Food Assistance Program
The University of Pittsburgh Medical Center, Center for Care of Infectious Diseases, Pittsburgh Area Center for Treatment (PACT) began implementing the Food Assistance Program in August 2017 to serve as a supplemental resource for people with HIV receiving care who experience food insecurity. The program helps bridge gaps in Supplemental Nutrition Assistance Program (SNAP) benefits and monthly food costs while promoting access to healthy foods and retention in HIV care.Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
-
Rapid ART: An Essential Strategy for Ending the HIV Epidemic
What HIV care providers can do to create a rapid ART program to get HIV clients on treatment the same day as a diagnosis.Resource updated 09/19/2023
-
Rapid ART Playbook Outlines Steps to Implementation
Guide on implementing rapid ART the administration of antiretroviral therapy (ART) as quickly as possible and ideally on the same day as an HIV diagnosis/clinic visit.Blog updated 03/03/2022
-
TAP-in EHE Webinar Series
Recordings of the TAP-in webinars on topics critical to the Ending the HIV Epidemic Initiative.Resource updated 05/23/2023
-
Merging Prevention and Care Planning Groups
HIV planning groups are responsible for overseeing the planning and implementation of HIV prevention and care activities within communities. Historically, prevention and care programs have operated separate planning groups. RWHAP Part A and Part B recipients and CDC-funded prevention jurisdictions have conducted parallel planning activities, oftentimes with little collaboration or coordination. As a way to reduce duplicative planning activities and streamline the work of planning groups, a number of jurisdictions have integrated their HIV planning groups.
Resource updated 09/14/2023
-
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
Online Course on Integrated Planning
-
Lights, Camera, Action: Introducing an Integrated HIV Prevention and Care Planning Online Course
Introduction to the newly developed online course, An Introduction to Integrated HIV Prevention and Care Planning.Resource updated 02/28/2022
-
An Introduction to HIV Prevention and Care Planning
This self-paced course from the Integrated HIV/AIDS Planning TA Center serves as an introduction to the fundamentals of integrated planning, and is designed for anyone who is new to integrated HIV prevention and care planning or anyone who would like a refresher on the basics.
By the end of this course, you will be able to:
Resource updated 07/28/2021
-
HIV Planning Body Assessment Guide: A Resource for Integrated HIV Planning Bodies
Guide to help integrated HIV planning bodies review and evaluate the effectiveness of their structure, policies and procedures, membership, and stakeholder and consumer engagement.Resource updated 09/14/2023
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Fostering Equity in HIV Planning
In this webinar, panelists discussed the ways in which power imbalances can manifest in HIV planning bodies; how their planning bodies have sought to promote equity; and strategies that can be implemented to foster equity and mitigate power imbalances based on race, education, age, and socioeconomic status.
Resource updated 11/22/2021
-
Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic
Recap of changes made in telehealth laws, regulations, and policies and corresponding efforts of healthcare systems, payers, and providers to modify their services to keep clients with HIV engaged in care provided by HRSA's Ryan White HIV/AIDS Program.Resource updated 06/09/2022
-
Reflections on COVID-19 Driven Telehealth Implementation in the RWHAP
The HRSA white page Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic offers lessons for future service delivery.Blog updated 01/23/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024